Device for needle biopsy with integrated needle protection

Information

  • Patent Grant
  • 11298113
  • Patent Number
    11,298,113
  • Date Filed
    Thursday, February 1, 2018
    7 years ago
  • Date Issued
    Tuesday, April 12, 2022
    3 years ago
Abstract
A device for needle biopsy is presented. The device includes a handle member having proximal and distal portions. A proximal handle member is disposed to the proximal portion of the handle member and a distal handle member is disposed to the distal portion of the handle member. A sheath lumen is disposed within the handle member and extends from the distal portion of the handle member. A needle housing member is partially disposed to the proximal portion of the handle member and a needle is disposed within the sheath lumen. A plurality of protrusions is disposed upon the needle. A needle protection member is partially disposed to the distal portion of the needle housing member. The needle protection member includes a needle protection hub and a needle protection shaft.
Description
BACKGROUND

Endoscopic ultrasound procedures have been used for more than twenty five years within the field of medicine. These procedures allow clinicians to scan, locate and identify individual layers of a patient's gastrointestinal tract to determine the location of individual mucosal and sub-mucosal layers. Once identified, appropriate therapeutic modes of treatment for malignancies and various abnormalities may be determined by a clinician.


An endoscopic ultrasound procedure may consist of several steps. For example, a clinician may sedate a patient and insert a probe via esophagogastroduodenoscopy into the patient's stomach and duodenum. An endoscope may then be passed through the patient's mouth and advanced to the level of the duodenum. From various positions between the esophagus and duodenum, organs or masses outside the gastrointestinal tract may be imaged to determine abnormalities. If any abnormalities are present, the organs or masses can be biopsied through fine needle aspiration. Organs such as the liver, pancreas and adrenal glands are easily biopsied as are any abnormal lymph nodes. A patient's gastrointestinal wall can also be imaged to determine the presence of any abnormalities. For example, abnormal thickness within a patient's gastrointestinal wall may be suggestive of inflammation or malignancy.


The quality of images produced via endoscopic ultrasounds is directly proportional to the level of frequency used. Although a high frequency ultrasound can produce a higher image quality, high frequency ultrasounds do not penetrate organ walls as well as lower frequency ultrasound. As a result, the examination of the nearby organs is not possible.


Mediastinoscopy is a prevailing method for determining the presence of nodal metastases in the mediastinum. Generally performed as an outpatient surgical procedure, mediastinoscopy is associated with a low rate of serious adverse effects and is considered to be highly accurate. Endobronchial ultrasound guided fine needle aspiration biopsy of mediastinal nodes offers a less invasive alternative for histologic sampling of the mediastinal nodes. Endobronchial ultrasound has been widely adopted by pulmonologists and is poised to replace mediastinoscopy in the future. For thoracic surgeons, endobronchial ultrasound can be easily learned and it may be important to do so if their specialty is to maintain the traditional and important role in the diagnosis and staging of thoracic malignancies.


During endobronchial ultrasound, a clinician can perform needle aspiration on lymph nodes using a bronchoscope inserted through the mouth. For an endobronchial ultrasound procedure, an endoscope fitted with an ultrasound processor and a fine-gauge aspiration needle is guided through a patient's trachea. Once appropriately positioned, the needle portion of the fine needle aspiration device is advanced into the lymph node, the sample aspirated, and device is removed from the bronchoscope.


Endoscopic ultrasounds and endoscopic bronchial ultrasounds through fine needle aspiration are presently standard modes of treatment in the field of gastrointestinal endoscopy and bronchoscopy. These procedures traditionally result in high yields of sensitivity and specificity in the management of indications of diseases such as esophageal cancer, pancreatic cancer, liver mass, non-small cell lung cancer, pancreatic mass, endobronchial mass, and intra-abdominal lymph nodes.


An endoscopic ultrasound through fine needle aspiration requires a fine needle aspiration device that is attached to the luer port or working channel of a typical echo-endoscope. Traditional devices utilize a series of push and pull handles to control the axial movement of the catheter shaft of the device and the depth of needle penetration. These device, however, suffer from several drawbacks.


For example, the means of attaching a device to an echo-endoscope is cumbersome. Devices presently utilize male fitting adapters that must be screwed onto a female luer port of an endoscope. In addition, these devices provide sub-optimal ergonomics of use. More specifically, a clinician must actuate a number of handles independently and lock respective handles in position via cap screw arrangement to secure the device. The cumulative actions required by a clinician result in significantly drawn out procedures. Further, needles commonly kink or deform during removal from a device causing numerous delays and failures. Moreover, multiple passes per procedure are required, which prolong the procedure and result in a clinician needing to reconfirm the location of a needle relative to a desired aspiration site with each new pass.


Another drawback involving a typical echoendoscope concerns the lack of needle safe preventative design features which protect the clinician from inadvertent needle penetration and the transfer of blood-borne pathogens from a patient to attending medical staff. In the case of currently available fine needle aspiration medical devices for both endoscopic ultrasound and endo-bronchial ultrasound, once a sample has been aspirated from the desired anatomical location, the fine needle aspiration catheter is removed from the echoendoscope and handed to the clinician for sample extraction and preparation. The clinician is instructed to “re-sheath” the needle (i.e. retract the needle into the catheter sheath) prior to detachment from the echo-endoscope. However, in many instances, this does not occur. As such, the needle sharp of the device is exposed during removal and transfer of the fine needle aspiration device among medical staff in the endoscopic ultrasound and endo-bronchial ultrasound suite with increased risk of “needle sticking” and blood borne pathogen contamination and exposure to same.


Additionally, needles are commonly used in medical procedures, with biopsy being a primary field of use for such devices. In the case of Endoscopic Ultrasound (EUS) and Endo-bronchial Ultrasound (EBUS), the efficiency of the ultrasonic procedure relies on the ability to direct the needle component to the desired site of sample acquisition. Smooth cylindrical surfaces of needles are unfortunately very difficult to image using ultrasonography due to the specular (mirror-like) surface finish of the needle in the untreated state. To address this problem, various techniques have been developed to enhance the echogenicty or ultrasonic visibility of needles. Various techniques (sandblasting, surface etching and coating of surfaces) have been used to “roughen” the surface of a needle component with limited success. This surface roughening results in a scattering of rays from the ultrasound. However, some of the drawbacks of the aforementioned techniques concern the angle of incidence (sound waves from the ultrasonic transducer) and the angle of reflection (sound waves reflected back to the transducer array). It is important that the method and design of surface finish and surface deformation imparted to the needle of the biopsy device maximize the percentage of waves reflective which can be picked up by the ultrasonic array.


Therefore, a need exists for improved devices for use in endoscopic ultrasound procedures.


SUMMARY

According to an aspect of the present disclosure, a device for needle biopsy is presented. The needle biopsy device is comprised of a handle member, a proximal handle member, a distal handle member, a sheath lumen, a needle housing member, a needle, a stylet, and ergonomic design features, including a conical grip, to enhance the maneuverability and operation of the device.


According to another aspect of the present disclosure, a device for needle biopsy is presented. The needle biopsy device is comprised of a handle member, a proximal handle member, a distal handle member, a sheath lumen, a needle housing member, a needle, a needle protection adaptor, and a needle protection member.


According to another aspect of the present disclosure, a device for needle biopsy is presented. The needle biopsy device is comprised of a handle member, including an engageable member, a proximal handle member, a distal handle member, a sheath lumen, a needle housing member, a land ring, a strain relief member, a needle containing a plurality of protrusions disposed thereon, a needle protection member, a needle protection hub, and a needle protection shaft.


According to yet another aspect of the present disclosure, a device for needle biopsy is presented. The needle biopsy device is comprised of a handle member, a proximal handle member, a distal handle member, a sheath lumen, a needle housing member, and a needle including a plurality of depressions to enhance echogenicity and ultrasonic visibility.


According to yet another aspect of the present disclosure, a device for needle biopsy is presented. The needle biopsy device is comprised of a handle member, a proximal handle member, a distal handle member, a sheath lumen, a needle housing member, and, a needle including a plurality of protrusions disposed thereon and a joint permitting detachment of the distal portion of the needle.


According to another aspect of the present disclosure, a device for needle biopsy is presented. The needle biopsy device is comprised of a handle member, a proximal handle member that is configured for slideable engagement and includes at least one guide-rail along its longitudinal axis to engage at least one recessed groove to control slideable movement, a distal handle member that is configured for slideable engagement and includes at least one guide-rail along the longitudinal axis to engage at least one recessed groove to control slideable movement, a sheath lumen, a needle housing member, and a needle.


According to another aspect of the present disclosure, a device for needle biopsy is presented. The needle biopsy device is comprised of a handle member, a proximal handle member, a distal handle member, a sheath lumen, a needle housing member, a needle, and a needle lock member.





BRIEF DESCRIPTION OF THE DRAWINGS

The objects and features of the present disclosure, which are believed to be novel, are set forth with particularity in the appended claims. The present disclosure, both as to its organization and manner of operation, together with further objectives and advantages, may be best understood by reference to the following description, taken in connection with the accompanying drawings as set forth below:



FIG. 1 is a cross-sectional view of an embodiment of a needle protection member, according to the present disclosure;



FIG. 2 is a cross-sectional view of an embodiment of a needle protection member, according to the present disclosure;



FIG. 3 is a cross-sectional view of another embodiment of a needle protection member, according to the present disclosure;



FIG. 4 is a perspective view of an embodiment of a needle protection adapter, according to the present disclosure;



FIG. 5 is a perspective view of an embodiment of a luer adapter, according to the present disclosure;



FIG. 6 is a perspective view of an embodiment of a luer adapter, according to the present disclosure;



FIG. 7 is a cross-sectional view of an embodiment of a needle protection member, according to the present disclosure;



FIG. 8 is a cross-sectional view of an embodiment of a needle protection member, according to the present disclosure;



FIG. 9 is a perspective view of an embodiment of a needle protection member, according to the present disclosure;



FIG. 10 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 11 is a perspective view of an embodiment of a needle protection member, according to the present disclosure;



FIG. 12 is a perspective view of an embodiment of a needle protection member, according to the present disclosure;



FIG. 13 is a perspective view of an embodiment of a needle protection member, according to the present disclosure;



FIG. 14 is a perspective view of an embodiment of a needle protection member, according to the present disclosure;



FIG. 15 is a perspective view of an embodiment of a needle protection member, according to the present disclosure;



FIG. 16 is a perspective view of an embodiment of a needle protection member, according to the present disclosure;



FIG. 17A is a perspective view of an embodiment of a needle lock member, according to the present disclosure;



FIG. 17B is a perspective view of an embodiment of a needle lock member, according to the present disclosure;



FIG. 18A is a perspective view of an embodiment of a needle protection member, according to the present disclosure;



FIG. 18B is a perspective view of an embodiment of a needle protection member, according to the present disclosure;



FIG. 19 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 20A is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 20B is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 20C is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 20D is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 20E is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 20F is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 20G is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 21 is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 22 is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 23A is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 23B is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 23C is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 23D is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 23E is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 24 is a flow diagram of ultra-sound waves, according to the present disclosure;



FIG. 25 is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 26 is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 27 is a perspective view of an embodiment of a needle, according to the present disclosure;



FIG. 28 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 29 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 30 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 31 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 32A is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 32B is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 32C is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 32D is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 33 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 34 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 35 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 36 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 37 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 38A is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 38B is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 39A is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 39B is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 40 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 41 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 42 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 43 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure;



FIG. 44 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure; and



FIG. 45 is a perspective view of an embodiment of a needle biopsy device, according to the present disclosure.





DETAILED DESCRIPTION

The exemplary embodiments of the present disclosure are discussed in terms of needle biopsy devices for collecting tissue, fluid, and cell samples from a patient in conjunction with an endoscopic ultrasound or endoscopic bronchial ultrasound. It is contemplated that various embodiments of needle biopsy devices may include a modular design. For example, the needle biopsy device may include a needle housing member that detaches from the proximal handle member of the device for each individual pass or aspirated sample taken by a clinician at the site of lesion or abnormality. In addition, potential design embodiments are disclosed herewith that facilitate needle sharp safety and protection thereof, when combined with devices that incorporate an integrated catheter drive, needle advancement, needle retraction mechanism, and needle in the same device.


It is envisioned that the present disclosure finds application to a wide variety of biopsy devices for the collection of samples from a patient. It is also envisioned that the present disclosure may be employed for collection of body fluids including those employed during procedures relating to phlebotomy, digestive, intestinal, urinary, and veterinary. It is contemplated that the present disclosure may be utilized with other needle biopsy applications including, but not limited to, fluid collection, catheters, catheter introducers, spinal and epidural biopsy, aphaeresis, and dialysis.


In the discussion that follows, the term “proximal” refers to a portion of a structure that is closer to a clinician, and the term “distal” refers to a portion that is further from the clinician. According to the present disclosure, the term “clinician” refers to an individual performing sample collection, installing or removing a needle from a needle biopsy device, and may include support personnel. Reference will now be made in detail to exemplary embodiments of the disclosure, which are illustrated in the accompanying figures.


Referring now to FIGS. 1 and 2, cross-sectional views of embodiments of a needle protection member 100 utilized with a luer port 108 of an echo-endoscope 110 is presented. Needle protection member 100 is comprised of a needle protection shaft 102 and a needle protection hub 104. The length of needle protection shaft 102 may be, for example, between four (4) to twenty (20) centimeters in order to protect a clinician from inadvertent piercing by a needle 114. Needle protection hub 104 is located at the proximal portion of needle protection member 100. In an embodiment, needle protection hub 104 is comprised of at least one engagable member 116. At least one engagable member may be, for example, a flange.


Needle protection member 100 may be manufactured from a compressible material such as polyurethane, polyetheramide or copolymers thereof, silicone, neoprene rubber, polyvinylchloride or copolymers thereof, polyethylene or derivatives thereof or other commercially available, low durometer polymers materials. The material of manufacture shall provide a compressible fit between needle protection member 100 and luer port 108 at the proximal end of echo-endoscope 110.


Needle protection member 100 resides over a sheath lumen 106. Needle protection member 100 is free to move over sheath lumen 106 at the proximal end of echo-endoscope 110. In an embodiment, needle protection member 100 is secured in position against luer port 108 as a clinician attaches a needle biopsy device (not shown in Figure) to echo-endoscope 110 by means screwing the luer lock adaptor of the needle biopsy device (not shown in Figure) onto luer port 108. Needle protection member 100 is held in position once the luer lock adaptor of the needle biopsy device is tightened onto luer port 108.


Sheath lumen 106 may consist of a polymer extruded component that is rigid in nature. Sheath lumen 106 may be comprised of, for example, thermoplastic materials. The thermoplastic materials may be, but are not limited to, polyurethane, polyamide and derivatives thereof, ether block amide copolymers, polyimide, polyethylene and derivates thereof, and polytetrafluoroethyelene. Sheath lumen 106 may also be comprised of a helically braided configuration of outer thermoplastic materials with a lubricious inner core.


Sheath lumen 106 incorporates at least one engagable member 112 that is complimentary to at least one engagable member 116 of needle protection member 100. Engagable member 112 represents a transition in the outer diameter of the distal portion of sheath lumen 106. The outer diameter of engagable member 112 may be, for example, of the order of 0.002″ to 0.050″ in outer diameter as well as of the order of 0.005″-0.020″.


In an embodiment of the present disclosure, a clinician may take measures to protect from inadvertent needle piercing by retracting sheath lumen 106 in a proximal direction. During the step of retraction, engagable member 112 communicates with engagable member 116. As engagable member 112 communicates with engagable member 116, needle protection member 100 disengages from luer port 108 and covers the distal portion of needle 114. Needle protection member 100 covers needle 114 even when needle 112 is at its maximum length of extension from the distal end of catheter sheath 106.


Referring to FIG. 3, a cross-sectional view of another embodiment of needle protection member 100 is presented. Needle protection member 100 consists of a compressible and deformable element 104 at its proximal end to provide for compression when inserted inside a luer port of an echo-endoscope (not shown in Figure). Needle protection member 100 further includes a needle protection shaft 118 and a land insert 120.


Needle protection shaft 118 may be manufactured from a rigid polymer such as polyurethane, polyamide and derivatives thereof, ether block amide copolymers, polyimide, polyethylene and derivates thereof, polytetrafluoroethyelene, or metal based elements such as stainless steel or derivatives thereof. In another embodiment, needle protection shaft 118 is manufactured from a stainless steel type material to provide a clinician with the ability to straighten a needle for re-insertion in the event that the needle becomes damaged as a result of continuous usage and passage during the acquisition of multiple samples. Needle protection shaft 118 may be over-molded to combine the requirements of compressibility with the rigidity of land insert 120.


Referring to FIG. 4, a perspective view of a needle protection adapter 200 is presented. Needle protection adaptor 200 is attached proximally to a luer adapter 202 and distally to a needle biopsy device 204. Needle protection adaptor 200 is comprised of a needle protection member 206, a needle protection shaft 208, an adapter member 210, and at least one engagable member 212.


Needle protection member 206 may be over-molded from thermoplastic material such as acrylonitrile butadiene styrene, polystyrene and derivatives thereof, polyetherkeytone, polyamide, polyethersulfone, polyurethane, ether block amide copolymers, polyacetal, polycarbonate and derivatives thereof. In an embodiment, needle protection shaft 208 consists of a stainless steel hypo-tube to provide rigidity and the ability to straighten a needle in the event that the needle may have become kinked during successive passages.


Adapter member 210 and engagable member 212 facilitate the engagement between luer adapter 202, needle protection adapter 200, and needle biopsy device 204. Adapter member 210 and engagable member 212 may be, for example, a screw thread or a snap-fit type of arrangement.


In an embodiment, needle protection adapter 200 is permanently attached to luer adapter 202. In another embodiment, luer adaptor 202 is connected to an echo-endoscope (not shown in Figure) via a screw thread type arrangement. Luer adapter 202 may be an over-molded component manufactured from a rigid or semi-rigid thermoplastic type polymer material such as acrylonitrile butadiene styrene, polystyrene and derivatives thereof, polyetherkeytone, polyamide, polyethersulfone, polyurethane, ether block amide copolymers, polyacetal, and derivatives thereof.


Referring to FIGS. 5 and 6, perspective views of embodiments of luer adapter 202 are presented. Luer adapter 202 may be attached to needle protection adaptor 200 via snap fit connections 214 and 216. Snap fit connections 214 and 216 allow a clinician to disengage an echo-endoscope (not shown in Figure) from luer adapter 202 with relative ease. For example, once a sample has been aspirated from a desired anatomical site, an echo-endoscope may be detached from the distal end of luer adapter 202.


Referring to FIGS. 7 and 8, cross-sectional views of embodiments of needle protection adapter 200 are presented. Needle protection adapter 200 is comprised of a needle protection member 206 that extends from the middle portion of needle protection adapter 200 through the distal portion of needle protection adapter 200. Needle protection member 206 is comprised of a needle protection shaft 208 and at least one engagable member 222 on its internal diameter.


In an embodiment of the present disclosure, as a clinician retracts a sheath lumen 218 in a proximal direction, engagable member 222 communicates with a complimentary engagable member 220 located on the distal portion of sheath lumen 218. For example, sheath lumen 218 reaches a junction when engagable member 220 contacts engagable member 222 at the proximal end of needle protection member 206. At this juncture, a clinician may detach needle protection adapter 200 from luer adapter 202 as a needle 224 is completely protected within needle protection shaft 208. In this manner, needle protection shaft 208 can cover the distally protruding portion of needle 224 even when needle 224 is at its maximum length of extension from the distal end of needle protection member 206.


Referring to FIGS. 9 through 12, perspective views of embodiments of a needle protection member 300 and a needle biopsy device 310 are presented. Needle protection member 300 is comprised of a needle protection hub 302 and a needle protection shaft 304. Needle protection hub may be manufactured from, for example, rigid or semi-rigid thermoplastic materials such as acrylonitrile butadiene styrene, polystyrene and derivatives thereof, polyetherkeytone, polyamide, polyethersulfone, polyurethane, polyethylene, ether block amide copolymers, polyacetal, polycarbonate and derivatives thereof.


Needle biopsy device 310 is comprised of a needle housing member 312, a proximal handle member 314, a handle member 316, and a distal handle member 318. In an embodiment of the present disclosure, needle protection member 300 is pre-mounted distally on needle housing member 312. As needle housing member 312 is advanced into proximal handle member 314, needle protection hub 302 and needle protection shaft 304 are secured between engagable members 320. For example, needle protection hub 302 may be substantially secured between engagable members 320 that are snap-fit arrangements in proximal handle member 314.


Referring now to FIGS. 13 through 16, perspective views of embodiments of needle protection hub 302 and needle protection shaft 304 are presented. Needle protection hub 302 and needle protection shaft 304 may be injection molded components that are molded from a range of commercially available rigid or semi-rigid thermoplastic materials. These materials may be, are not limited to, acrylonitrile butadiene styrene, polystyrene and derivatives thereof, polyetherkeytone, polyamide, polyethersulfone, polyurethane, ether block amide copolymers, polyacetal, polycarbonate and derivatives thereof. In an embodiment, needle protection hub 302 and needle protection shaft 304 are also comprised of materials that are transparent or translucent in nature, such as polystyrene, polycarbonate, and styrene acrylonitrile. It is envisioned that the transparent or translucent function provides clinicians with visual feedback as to the location of a needle 324 relative to the distal portion of the needle protection shaft 304.


In an embodiment of the present disclosure, needle 324 includes engagable members 322 that are separated at a specific distance from the distal portion of needle 324. The location of engagable members 322 along needle 324 correspond to the maximum allowable length for needle penetration during sample acquisition. Engagable members 322 may be, for example, extruded polymeric spacers. As a clinician retracts needle 324 through needle protection shaft 322, needle protection hub 302 remains locked in proximal handle member 314 until at least one engagable member 322 engages a corresponding engagable member within needle protection hub 302. At this juncture, as the clinician applies additional retraction force, needle protection hub 302 disengages from engagement member 320 and needle 324 is encased as it is retracted from proximal handle member 314, thereby preventing inadvertent needle stick.


Referring to FIGS. 17A and 17B, perspective views of embodiments of a needle lock member are presented. In an embodiment of the present disclosure, needle lock member is comprised of a compression gasket 400, a compression fitting hub 410, and a cylindrical barrel 412. A needle 402 is partially disposed within compression gasket 400 and cylindrical barrel 412. Compression gasket 400 is partially disposed within compression fitting hub 410 and cylindrical barrel 412 is partially disposed within compression gasket 400. Compression gasket 400 may be, for example, manufactured from silicone and other soft deformable polymeric or rubber materials that can be compressed or decompressed as desired.


In an embodiment, compression gasket 400 may be in a compressed state 404 or an uncompressed state 405. Referring now to FIG. 17A, in compressed state 404, compression gasket 400 is in contact with a portion of needle 402, thereby preventing needle 402 from being advanced or retracted out of the distal end of a catheter sheath 406. At this juncture, the clinician may attach an adaptor 408 to an echo-endoscope by engaging the luer component of the working channel of the scope (not shown in Figure) with adaptor 408. Referring now to FIG. 17B, the clinician may then rotate compression fitting hub 410, thereby connecting compression fitting hub 410 onto adaptor 408. This rotational motion results in compression gasket 400 being displaced in a distal direction. This rotation also results in the displacement of cylindrical barrel 412 through compression gasket 400 at its proximal end. At this juncture, once compression fitting hub 410 and adaptor 408 are secured in place, compression gasket 400 is no longer in contact with needle 402. Needle 402 may then advance or retract freely to acquire a desired sample.


Referring to FIGS. 18A and 18B, perspective views of embodiments of needle protection mechanisms for use with a needle biopsy device 500 and 510 are presented. Needle biopsy device 500 is comprised of a needle housing member 502, a proximal handle member 504, and a handle member 506. Needle housing member 502 includes a needle therein. Needle biopsy device 510 is comprised of a proximal handle member 512 and a handle member 516.


In an embodiment, needle housing member 502 is fully inserted into proximal handle member 504 to allow the needle to extend from the distal end of the sheath lumen (not shown in Figure). In this regard, once a clinician has acquired a tissue sample, the clinician may retract proximal handle 504 to its maximum stroke to ensure that the needle becomes housed within the distal portion of the sheath lumen. In order to facilitate this process, needle biopsy device 500 incorporates a first engagable member 508 at the proximal end of proximal handle member 504, a second engagable member 514, and a third engagable member 518 at the proximal end of the handle member 516. The use of such engagable members prevents proximal handle member 504 from moving forward without the application of force by the clinician. This feature also provides tactile feedback to alert the clinician that the needle is locked because the clinician can feel engagable members 508, 514, and 518 clicks into position. It is contemplated that this design feature also ensures that the clinician is not solely reliant on having to lock the locking slide ring in place prior to removal of sheath lumen 506. It is further contemplated that incorporating a self-locking mechanism such as engagable members 508, 514, and 518 also eliminates the need for the clinician to lock the locking slide ring in place, thereby also increasing procedural efficiency. Furthermore, by leaving the locking ring locked at a specific location on handle member 504, the clinician can maintain needle penetration settings between successive needle passes in acquiring multiple tissue samples.


Referring to FIG. 19, a perspective view of another embodiment of a needle biopsy device 520 is presented. Needle biopsy device 520 is comprised of an adaptor 522, a proximal handle member 524, ergonomic design features 526 and 528 disposed on proximal handle member 524 and distal handle member (not shown in Figure), a locking ring 532, and a needle 530. In an embodiment, needle biopsy device 520 does not facilitate catheter shaft adjustment when needle biopsy device 520 is attached to an echo-endoscope.


Proximal handle member 524 incorporates ergonomic design features 526 and 528 in order to provide a clinician with enhanced feel of needle biopsy device 520. Ergonomic features 526 and 528 may be, for example, a conical grip or depressions suitable for a thumb or forefinger. Locking ring 532 allows a clinician to lock the depth of needle extension from the end of the sheath lumen of the device. Locking ring 532 may be moved distally or proximally and can be locked in position via tightening.


Referring now to FIGS. 20A through 24, perspective views of embodiments of a design feature for needles are presented. The needle incorporates echogenic features over its length of the distal end when exposed to its maximum extension length. This functionality is achieved through the removal of material from the surface of the needle to provide greater reflectivity and strengthened reflected signal. It is contemplated that the removal of material does not, however, reduce the performance of the needle from a pushability perspective or deter its ability to acquire a desired sample.


Referring now to FIG. 20A, a perspective view of an embodiment of a needle 600 is presented. Needle 600 is comprised of a plurality of depressions 602. Depressions 602 may be, but are not limited to, circular, concave, cylindrical, helical, oval, rectangular, and square elements that take the form of indentations on the surface of needle 600. Depressions 602 may be arranged in a helical (spiral) fashion around the circumference of the distal needle end. These indentations may extend to the extreme end of the bevel or may end at a specific distance from the bevel of needle 600. The length of the distal end of needle 600 containing these depressions may be, for example, from one to twenty centimeters. In another embodiment, the length is between five to ten centimeters. Referring to FIGS. 20B and 20C, depression 602 have a concave detail 604. Referring to FIGS. 20D and 20E, depressions 602 have a square base edge 606. Referring to FIGS. 20F and 20G, depressions 602 have a hemispherical base detail 608.


Referring now to FIG. 21, a perspective view of another embodiment of a needle 610 is presented. Needle 610 is comprised of elliptical depressions 612 around the circumference of the distal end of needle 610. Referring to FIG. 22, a perspective view of an embodiment of a needle 614 having square depressions 616 is presented. Depressions 616 may extend to the extreme end of the bevel or may end at a specific distance from the bevel of needle 614. Referring to FIGS. 23A and 23B, embodiments of needle 614 including spiral depressions 620 and helical depressions 622 are presented. Referring to FIGS. 23C, a depression 624 has a concave detail. Referring to FIGS. 23D, a depression 626 has a square base edge. Referring to FIGS. 23E, a depression 628 has a hemispherical base detail.


Referring now to FIG. 24, a diagram of ultrasound waves impinging upon a needle depression at angles of α1630 and β1632 respectively are presented. In an embodiment, a wave strikes the base of the depression and is reflected upwards at angle of reflection of α2634 and β2636 respectively, which are equal to the angles of incidence of α1630 and β1632 respectively. This reflected beam is reflected a second time off the adjacent wall of the depression at an angle of reflection of α3638 and β3640 respectively, which are equal to the angles of incidence, α1630 and β1632 respectively and the angles of first reflection α2634 and β2636 respectively. In this manner, the reflected wave becomes reflected along the same angle of incidence as the initially propagated incident beam back to the transducer of the ultrasound device. In an embodiment, a square edge depression design may provide for more efficient remittance of ultrasound waves during the procedure.


Referring now to FIGS. 25 through 27, perspective views of an embodiment of another design feature for a needle 700 are presented. Needle 700 is comprised of a filter element 702, at least one protrusion 706, a joint 708, and is housed within a needle protection member 704.


In an embodiment of the present disclosure, joint 708 permits a clinician to detach the distal portion of needle 700 from the main body of needle 700. Joint 708 may be, for example, a lap, snap-fit, or adhesive joint arrangement. It is envisioned that joint 708 shall not compromise the pushability or kink resistance of needle 700 during sample extraction.


Filter element 702 acts as a membrane to capture cells acquired during an aspiration process. During a procedure, post-aspiration, a clinician may detach the needle housing member from the handle of the needle biopsy device at the proximal handle end. Once completely retracted, the sharp end of needle 700 is protected by needle protector 704. Once a clinician detaches needle 700 at joint 708, he or she may safely insert needle 700 into a vile for laboratorial analysis. In this manner, the efficiency of a fine-needle aspiration procedure may be improved by eliminating sample prep time in the EUS or EBUS suite, which is normally taken up with waiting for the sample to be removed from needle 700 before a successive needle pass may be made.


Referring now to FIGS. 28 through 45, various embodiments of a needle biopsy device with an exchangeable needle housing member are presented. Referring to FIGS. 28 and 29, a needle biopsy device 800 is presented. Needle biopsy device 800 is comprised of a proximal handle member 802, a proximal inner handle member 804, a proximal guide-rail 805, a stop member 806, a distal guide-rail 807, a distal inner handle member 808, a distal handle member 810, a needle housing member 812, a stylet 814, a release member 816, a sheath lumen 818, a needle protection hub 820, a needle protection shaft 822, a ring engagable member 824, a proximal inner handle shaft 826, and a needle 828.


Proximal handle member 802 is used to provide a slideable method to advance and retract needle 828 along proximal inner handle member 804. For example, proximal guide-rail 805 located at the distal end of the proximal inner handle member 804 provides recess grooves to allow movement of needle 828 into and out of a tumerous location.


Distal handle member 810 is used to provide a slideable method to adjust the protrusion depth of sheath lumen 818 relative to the extended length of needle 828 along distal inner handle member 808.


In an embodiment, needle housing member 812 is pre-loaded with an integrated needle protection mechanism (not shown in Figure). It is contemplated that once a clinician has acquired a cellular sample, needle housing member 812 may be unlocked from proximal handle member 802 by depressing release member 816. Release member 816, may be, for example, an external push-button hinge. The act of manipulating release member 816 allows a clinician to unlock needle housing member 812 and retract the needle from device 800.


Referring to FIGS. 30 and 31, a perspective view of an embodiment of proximal handle member 802 is presented. Proximal handle member 802 is comprised of recessed portions 830 to allow for the positioning of ring engagable member 824 and proximal guide rails 805. Proximal handle member 802 is free to slide forward and backward along proximal guide rail 805, thus allowing the clinician to advance or retract the needle during a procedure. It is contemplated that the distal handle member (not shown in Figure) is free to slide forward and backward along the distal guide-rail, allowing to clinician to adjust the depth of sheath lumen 818 extension beyond the end of an echo-endoscope.


Referring to FIGS. 32A through 32D, perspective views of components of the handle members are presented. Distal handle member 810 is comprised of at least one bore recess 834, a locking engagement bore 836, and a luer recess 838. In an embodiment, a threaded spacer may be inserted into bore recess 834 and secured in position. The step of securing may be performed by, for example, a mechanical press-fit or via the use of adhesive.


Proximal inner handle member 804 and distal inner handle member 808 are separated by a stop member 806. Stop member 806 acts as a divider to control the advancement and retraction of the handle member components along proximal inner handle member 804 and distal inner handle member 808. In an embodiment, stop member 806 is secured to a proximal member recess 840. It is contemplated that stop member 806 does not interfere with the functionality of a tapered passage 842 for needle exchange and a land bore 844.


Referring now to FIG. 33, a perspective view of an embodiment of needle housing member 812 is presented. Needle housing member 812 is comprised of a land ring 813 and a stylet 814. Land ring 813 functions in conjunction with release member 816. The functional aspects of land ring 813 are described in further detail below.


Referring now to FIG. 34, a cross-sectional view of an embodiment of needle housing member 812 is presented. Needle housing member 812 is comprised of ring engagable member 824, a needle luer hub 840, an inner housing 842, a needle strain relief member 844. In an embodiment, inner housing 842 incorporates a shelf that engages and disengages with release member 816 (as shown in FIG. 29). This design feature provides the clinician with a smooth locking response when securing the needle housing member to the assembly of release member 816. Needle luer hub 840 may be secured to needle housing member 812 via various securing means, such as adhesive bonding, welding, brazing or soldering techniques. Inner housing 842 serves as a coupler to hold needle strain relief member 844 in position.


Referring now to FIGS. 35 through 37, perspective views of embodiments of needle protection hub 820 for use with needle housing member 812 are presented. Needle protection hub 820 includes an engagable member 846. Engagable member 846 communicates with protrusions 848 at the distal end of the needle. As a needle is continually retracted, the most proximal protrusion 848 interfaces with engagable member 846 and becomes mechanically locked thereto. At this juncture, as the clinician retracts the needle housing member from the proximal handle, needle protection hub 820 remains locked to protrusion 848, thus encasing the sharp bevel of the needle and protecting the clinician after the needle has been removed from the patient.


Needle protection hub 820 may be manufactured from, for example, a rigid, non-deformable metallic, thermoplastic or thermoset materials such as aluminum, stainless steel, acrylonitrile butadiene styrene (ABS), styrene acrylonitrile (SAN) or rigid derivatives thereof, polyamide, polyethylene, polyurethane, and polycarbonate. In an embodiment, these materials shall have a durometer in the range of 35-120 Shore D, but more preferably in the range of 80-110 Shore D.


It is envisioned that engagable members 846 may be manufactured from a range of low durometer, thermoplastic or thermoset materials such as, but not limited to, polyurethane and derivatives thereof, polyether amide block copolymers, polyamide, styrene butadiene rubber and/or alternate derivatives of styrene based polymers, neoprene, and polyethylene and derivatives thereof. In an embodiment, the materials of manufacture shall have a durometer in the range of 70-120 Shore A, but more preferably in the range of 70-90 Shore A.


Referring now to FIGS. 38A through 39B, various views of an embodiment of release member 816 are presented. Release member 816 represents a mechanism to attach the needle housing member to the proximal handle member of the needle biopsy device. Release member 816 may be, for example, a push-button, that activates the use of a hinge member 850 to provide for a return to the “Home” position once external force is not applied to release member 816. Hinge member 850 can elastically deform to provide for the opening and closing of the “lock” during removal of the needle housing member. In an embodiment, release member 816 incorporates an external coupler housing 852 and a push button 816 design mechanism. Referring now to FIGS. 39A and 39B, release member 816 illustrates release member 816 in the CLOSED and OPEN positions during a typical actuation cycle.


Referring now to FIGS. 38A and 38B, release member 816 and external coupler housing 852 may be manufactured from a range of rigid, non-deformable, thermoplastic or thermoset materials such as, acrylonitrile butadiene styrene (ABS), styrene acrylonitrile (SAN), polystyrene or rigid derivatives thereof, polyamide, polyethylene, polyurethane, and polycarbonate. In an embodiment, the materials of manufacture have a durometer in the range of 35-120 Shore D, but more preferably in the range of 80-110 Shore D.


Hinge member 850 may be manufactured from a range of rigid, thermoplastic or thermoset materials such as, acrylonitrile butadiene styrene (ABS), styrene acrylonitrile (SAN), polystyrene or rigid derivatives thereof, polyamide, polyethylene, polyurethane, and polycarbonate. In an embodiment, the materials of manufacture shall be capable of deformation in bending under the application of an applied load, such as is encountered during a typical “Open and Close” cycle for the needle biopsy device without crazing, fatigue or cracking.


Referring to FIGS. 40 through 42, perspective views of embodiments of needle protection member 820 in use with a needle biopsy device are presented. In an embodiment, the needle housing member is pre-mounted with needle protection hub 820 and needle protection shaft 822. Thereafter, the needle housing member is inserted into the proximal end of the proximal handle member with release member 816. The needle housing member is continually advanced until the taper portion of needle protection hub 820 is seated against ring engagable member 824. The application of additional force pushes needle protection hub 820 forward and ring engagable member 824 deforms until comes to rest. At this juncture, needle protection hub 820 is locked in position and does not move. In addition, the land ring of the needle housing member actuates the release member 816 until release member 816 crosses a “land ring” detail on the external surface of a coupler. At equilibrium, release member 816 is in its fully extended state and the coupler is locked in position.


An intended functionality of release member 816 is to prevent the needle housing member from being removed from the proximal handle member without applying force to release member 816. For example, once a sample has been aspirated from an intended site, release member 816 is actuated and the needle retracted. The needle is continually retracted until the most proximal engageable member 848 engages with needle protection hub 820. Retracting the needle still further with the application of additional force can cause the proximal radius of the taper to contact the ring engagable member 824. Ring engagable member 840 elastically distends and needle protection hub 820 traverses ring engagable member 840. As a result, the needle housing member can now be fully retracted from the device with the distal sharp of the needle protected from inadvertent sticking. Additionally, follow-up samples may be acquired using the same or a virgin needle housing member. Once the needle housing member has been loaded and locked into the coupler, the needle sub-assembly may be rotated. It is envisioned that the ability to core tissue during acquisition, by rotating and advancing and retracting the needle in short strokes, may be provided for.


Referring to FIG. 43, a perspective view of an embodiment of a coupler 854 is presented. In an embodiment, coupler 854 may utilize an O-Ring to provide for smooth locking of the needle housing member to the release member mechanism. In another embodiment, the O-Ring may be removed and the needle housing member may be utilized without such a component.


Referring now to FIG. 44, a perspective view of an embodiment of the needle biopsy device is presented. Proximal inner handle member 804 and distal inner handle member 808 provide for use of locking adjustment mechanisms, such threaded thumb screws to provide a frictional lock to the proximal and distal inner handle member components to lock both needle penetration depth and sheath lumen penetration depths respectively.


Referring now to FIG. 45, a perspective view of an embodiment of a ring engagable member 856 incorporated as part of the proximal inner handle member 804 is presented. In an embodiment, ring engagable member 856 is located in a recessed circular slot in the proximal inner handle member 804. During advancement and retraction of proximal handle member 802 in distal and proximal directions, the proximal inner handle member 804 slides distal and proximal to the inner member across ring expandable member 856. In this instance, ring expandable member 856 provides frictional force resistance between the proximal inner handle member 804 and proximal handle member 802. It is envisioned that when the clinician removes his/her hand from proximal handle member 802, ring expandable member 856 creates sufficient frictional force with the proximal inner handle member 804 that proximal handle member 802 remains at its location and is fixed to proximal inner handle member 804. In this way, the clinician may stop advancement or retraction of the proximal handle member 802 and the handle remains at that location.


Ring expandable member 856 may be manufactured from a range of low durometer, deformable, thermoplastic or thermoset materials such as, but not limited to polyurethane and derivatives thereof, polyether amide block copolymers, polyamide, styrene butadiene rubber and/or alternate derivatives of styrene based polymers, neoprene, and polyethylene and derivatives thereof. In an embodiment, the materials of manufacture have a durometer in the range of 70-120 Shore A, but more preferably in the range of 70-90 Shore A. Such O-Ring components are readily available from a range of companies such as McMaster-Carr by means of an example.


It will be understood that various modifications may be made to the embodiments disclosed herein. Therefore, the above description should not be construed as limiting, but merely as exemplifications of the various embodiments of the invention. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.

Claims
  • 1. A needle biopsy device comprising: a release member disposed at a proximal end of a handle and comprising an engageable portion that releasably engages a needle housing member disposed within the handle;a needle protection hub disposed within the handle and coupled to the needle housing member;a needle comprising a protrusion proximate to a distal end of the needle; and a needle protection shaft disposed within the handle and coupled to the needle protection hub, wherein the needle protection shaft comprises a lumen with an inner diameter larger than an outer diameter of the protrusion of the needle,wherein the protrusion of the needle is slideably disposed within the needle protection shaft as the needle is withdrawn in a proximal direction,wherein the protrusion of the needle is configured to traverse a protruded portion disposed within the handle in response to depressing the release member of the handle and withdrawing the needle in the proximal direction such that the protrusion of the needle locks onto a protruded portion of the needle protection hub and the release member disengages from the needle housing member, thereby withdrawing the needle from the lumen of the handle after the release member disengages from the needle housing member.
  • 2. The needle biopsy device of claim 1, further comprising: a sheath disposed at a distal end of the handle, coaxial with an axial lumen of the handle, and extending distally from the distal end of the handle.
  • 3. The needle biopsy device of claim 1, wherein the protrusion comprises a distal taper and a proximal taper.
  • 4. The needle biopsy device of claim 1, further comprising: a stylet disposed within the needle.
  • 5. The needle biopsy device of claim 1, wherein the release member comprises a deflecting hinge.
  • 6. The needle biopsy device of claim 5, wherein depression of the release member causes the needle housing member to release from the release member of the handle.
  • 7. The needle biopsy device of claim 1, further comprising: the needle housing member coupled to a proximal end of the needle.
  • 8. The needle biopsy device of claim 7, wherein the needle housing member further comprises: one or more indentations configured to limit rotation of the needle housing member with respect to the handle when the needle housing member engages the release member of the handle.
  • 9. The needle biopsy device of claim 7, wherein the release member further comprises: a cylindrical section that partially overlaps an axial lumen of the handle such that the cylindrical section is configured to releasably engage the needle housing member.
  • 10. The needle biopsy device of claim 7, wherein the needle housing member is removed from the handle in the proximal direction when the release member disengages from the needle housing member.
  • 11. The needle biopsy device of claim 7, wherein the protruded portion disposed within the handle further comprises an O-ring disposed distal to the release member.
  • 12. The needle biopsy device of claim 11, wherein the O-ring is disposed within an axial lumen of the handle.
  • 13. The needle biopsy device of claim 11, wherein the needle protection hub is coupled to a proximal end of the needle protection shaft, wherein the needle protection hub comprises a taper portion configured to seat against the O-ring.
  • 14. The needle biopsy device of claim 13, wherein the needle housing member is removed from the handle in the proximal direction when the protrusion of the needle engages the needle protection hub.
  • 15. The needle biopsy device of claim 13, wherein the needle protection hub disengages from the O-ring when the protrusion of the needle engages the needle protection hub.
  • 16. The needle biopsy device of claim 13, wherein the needle protection shaft extends beyond the distal end of the needle when the protrusion of the needle engages the needle protection hub.
  • 17. The needle biopsy device of claim 13, wherein the O-ring is configured to engage a proximal end of the needle protection hub when the needle housing member is inserted into the handle.
  • 18. The needle biopsy device of claim 17, wherein the O-ring is configured to circumscribe the proximal end of the needle protection hub when the needle housing member engages the release member of the handle in a locked configuration.
  • 19. The needle biopsy device of claim 13, wherein a distal end of the needle housing member contacts a proximal end of the needle protection hub when the needle housing member engages the release member of the handle.
  • 20. The needle biopsy device of claim 19, wherein the needle protection hub seats against the O-ring when the needle housing member engages the release member of the handle.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of prior U.S. patent application Ser. No. 14/630,742, filed Feb. 25, 2015, which is a continuation of U.S. patent application Ser. No. 12/607,636, filed Oct. 28, 2009, now U.S. Pat. No. 8,968,210, which is a Continuation-In-Part application of U.S. patent application Ser. No. 12/243,367, filed on Oct. 1, 2008, now U.S. Pat. No. 9,186,128, and claims the benefit of U.S. Provisional Application No. 61/117,966, filed on Nov. 26, 2008, the entire contents of each are incorporated herein by reference.

US Referenced Citations (748)
Number Name Date Kind
3612050 Sheridan Oct 1971 A
3666808 Meek May 1972 A
4098660 McLaughlin Jun 1978 A
4249541 Pratt Feb 1981 A
4356828 Jamshidi Nov 1982 A
4467816 Schluter et al. Aug 1984 A
4655226 Lee Apr 1987 A
4819637 Dormandy, Jr. et al. Apr 1989 A
4838280 Haaga Jun 1989 A
4857057 Sanagi Aug 1989 A
4861341 Woodburn Aug 1989 A
4893635 de Groot et al. Jan 1990 A
4903523 Flynn Feb 1990 A
4966162 Wang Oct 1990 A
4995866 Amplatz et al. Feb 1991 A
5054310 Flynn Oct 1991 A
5057085 Kopans Oct 1991 A
5111829 Alvarez de Toledo May 1992 A
5131393 Ishiguro et al. Jul 1992 A
5167239 Cohen et al. Dec 1992 A
5215528 Purdy et al. Jun 1993 A
5257628 Ishiguro et al. Nov 1993 A
5266359 Spielvogel Nov 1993 A
5277199 DuBois et al. Jan 1994 A
5281408 Unger Jan 1994 A
5320627 Sorensen et al. Jun 1994 A
5333613 Tickner et al. Aug 1994 A
5368036 Tanaka et al. Nov 1994 A
5376075 Haughton Dec 1994 A
5380292 Wilson Jan 1995 A
5419310 Frassica et al. May 1995 A
5456673 Ziegler Oct 1995 A
5458112 Weaver Oct 1995 A
5470308 Edwards et al. Nov 1995 A
5471988 Fujio et al. Dec 1995 A
5480389 McWha et al. Jan 1996 A
5490521 Davis et al. Feb 1996 A
5526822 Burbank et al. Jun 1996 A
5595724 Grier Jan 1997 A
5601588 Tonomura et al. Feb 1997 A
5607389 Edwards et al. Mar 1997 A
5609850 Deutsch et al. Mar 1997 A
5636255 Ellis Jun 1997 A
5681348 Sato Oct 1997 A
5688490 Tournier et al. Nov 1997 A
5695491 Silverstein Dec 1997 A
5775333 Burbank et al. Jul 1998 A
5779686 Sato Jul 1998 A
5800445 Ratcliff et al. Sep 1998 A
5801057 Smart et al. Sep 1998 A
5810806 Ritchart et al. Sep 1998 A
5810835 Ryan et al. Sep 1998 A
5848978 Cecchi Dec 1998 A
5888201 Stinson et al. Mar 1999 A
5902310 Foerster et al. May 1999 A
5919172 Golba, Jr. Jul 1999 A
5921933 Sarkis et al. Jul 1999 A
5928164 Burbank et al. Jul 1999 A
5938635 Kuhle Aug 1999 A
5941890 Voegele et al. Aug 1999 A
5944673 Gregoire et al. Aug 1999 A
5947964 Eggers et al. Sep 1999 A
5964740 Ouchi Oct 1999 A
5967988 Briscoe et al. Oct 1999 A
5968022 Saito Oct 1999 A
5980469 Burbank et al. Nov 1999 A
6019733 Farascioni Feb 2000 A
6045497 Schweich, Jr. et al. Apr 2000 A
6077248 Zumschlinge Jun 2000 A
6080115 Rubinstein Jun 2000 A
6106473 Violante et al. Aug 2000 A
6106524 Eggers et al. Aug 2000 A
6117108 Woehr et al. Sep 2000 A
6126633 Kaji et al. Oct 2000 A
6133316 Ostensen et al. Oct 2000 A
6149598 Tanaka Nov 2000 A
6161034 Burbank et al. Dec 2000 A
6168779 Barsky et al. Jan 2001 B1
6171249 Chin et al. Jan 2001 B1
6174291 McMahon et al. Jan 2001 B1
6179809 Khairkhahan et al. Jan 2001 B1
6193692 Harris et al. Feb 2001 B1
6221622 Love Apr 2001 B1
6228039 Binmoeller May 2001 B1
6228049 Schroeder et al. May 2001 B1
6231515 Moore et al. May 2001 B1
6261302 Voegele et al. Jul 2001 B1
6273861 Bates et al. Aug 2001 B1
6280399 Rossin et al. Aug 2001 B1
6287304 Eggers et al. Sep 2001 B1
6312428 Eggers et al. Nov 2001 B1
6323335 Huang Nov 2001 B1
6328701 Terwilliger Dec 2001 B1
6333155 Lockhart et al. Dec 2001 B1
6334067 Brabrand Dec 2001 B1
6336812 Cooper et al. Jan 2002 B1
6337994 Stoianovici et al. Jan 2002 B1
6338968 Hefti Jan 2002 B1
6340563 Finkelstein et al. Jan 2002 B1
6340565 Oliner et al. Jan 2002 B1
6340568 Hefti Jan 2002 B2
6344316 Lockhart et al. Feb 2002 B1
6344317 Urnovitz Feb 2002 B2
6347240 Foley et al. Feb 2002 B1
6347241 Burbank et al. Feb 2002 B2
6350244 Fisher Feb 2002 B1
6350274 Li Feb 2002 B1
6350583 Cohen et al. Feb 2002 B1
6351660 Burke et al. Feb 2002 B1
6355033 Moorman et al. Mar 2002 B1
6355275 Klein Mar 2002 B1
6355424 Lorincz et al. Mar 2002 B1
6356782 Sirimanne et al. Mar 2002 B1
6361499 Bates et al. Mar 2002 B1
6361948 Tricoli et al. Mar 2002 B1
6364526 Ivan et al. Apr 2002 B2
6365362 Terstappen et al. Apr 2002 B1
6365712 Kelly Apr 2002 B1
6368280 Cermak et al. Apr 2002 B1
6368292 Ogden et al. Apr 2002 B1
6368792 Billing-Medel et al. Apr 2002 B1
6368795 Hefti Apr 2002 B1
6368799 Chee Apr 2002 B1
6369195 An et al. Apr 2002 B1
6371904 Sirimanne et al. Apr 2002 B1
6371917 Ferrara et al. Apr 2002 B1
6372431 Cunningham et al. Apr 2002 B1
6372444 Powers et al. Apr 2002 B1
6374135 Bucholz Apr 2002 B1
6375634 Carroll Apr 2002 B1
6375953 Srivastava et al. Apr 2002 B1
6376258 Hefti Apr 2002 B2
6379671 Colpitts Apr 2002 B1
6379672 Srivastava et al. Apr 2002 B1
6383484 Achen et al. May 2002 B1
6383491 Srivastava et al. May 2002 B1
6383492 Srivastava et al. May 2002 B1
6383493 Srivastava et al. May 2002 B1
6387056 Kieturakis May 2002 B1
6387374 Srivastava et al. May 2002 B1
6387629 Schneider et al. May 2002 B1
6391306 Srivastava et al. May 2002 B1
6391542 Anderson et al. May 2002 B1
6391543 Billing-Medel et al. May 2002 B2
6394965 Klein May 2002 B1
6395480 Hefti May 2002 B1
6398737 Moore et al. Jun 2002 B2
6399069 Srivastava et al. Jun 2002 B1
6399070 Srivastava et al. Jun 2002 B1
6399371 Falduto et al. Jun 2002 B1
6402701 Kaplan et al. Jun 2002 B1
6403095 Srivastava et al. Jun 2002 B1
6405733 Fogarty et al. Jun 2002 B1
6407125 Fernandez-Pol Jun 2002 B1
6409664 Kattan et al. Jun 2002 B1
6410028 Srivastava Jun 2002 B1
6410229 Lockhart et al. Jun 2002 B1
6413751 Benkovic et al. Jul 2002 B1
6416484 Miller et al. Jul 2002 B1
6421559 Pearlman Jul 2002 B1
6423081 Lee et al. Jul 2002 B1
6423313 Esmon et al. Jul 2002 B1
6423489 Anderson et al. Jul 2002 B1
6423494 Jin et al. Jul 2002 B1
6423503 Mikolajczyk et al. Jul 2002 B1
6426195 Zhong et al. Jul 2002 B1
6426367 Das Jul 2002 B1
6427081 Burbank et al. Jul 2002 B1
6427089 Knowlton Jul 2002 B1
6428463 Ravins et al. Aug 2002 B1
6428479 Aksnes et al. Aug 2002 B1
6428487 Burdorff et al. Aug 2002 B1
6432035 Ravins et al. Aug 2002 B1
6432053 Fecht et al. Aug 2002 B1
6432065 Burdorff et al. Aug 2002 B1
6432700 Henderson et al. Aug 2002 B1
6434415 Foley et al. Aug 2002 B1
6436054 Viola et al. Aug 2002 B1
6436120 Meglin Aug 2002 B1
6436394 Henderson et al. Aug 2002 B1
6436404 Srivastava et al. Aug 2002 B1
6436411 Riordan et al. Aug 2002 B1
6440086 Hohenberg Aug 2002 B1
6440147 Lee et al. Aug 2002 B1
6440151 Cragg et al. Aug 2002 B1
6440153 Cragg et al. Aug 2002 B2
6443960 Brabrand et al. Sep 2002 B1
6445767 Karellas Sep 2002 B1
6447477 Burney et al. Sep 2002 B2
6447534 Cragg et al. Sep 2002 B2
6447780 Srivastava et al. Sep 2002 B1
6447781 Srivastava Sep 2002 B1
6447997 Los et al. Sep 2002 B1
6448020 Toftgard et al. Sep 2002 B1
6450973 Murphy Sep 2002 B1
6455027 Barsky et al. Sep 2002 B1
6455048 Srivastava et al. Sep 2002 B1
6455251 Waldman Sep 2002 B1
6459925 Nields et al. Oct 2002 B1
6461615 Srivastava Oct 2002 B1
6463319 Bucholz Oct 2002 B1
6464648 Nakamura Oct 2002 B1
6465181 Billing-Medel et al. Oct 2002 B2
6465183 Wober Oct 2002 B2
6468985 Huang Oct 2002 B1
6470217 Fenn et al. Oct 2002 B1
6471659 Eggers et al. Oct 2002 B2
6471678 Alvarez de Toledo Oct 2002 B1
6471700 Burbank et al. Oct 2002 B1
6471709 Fawzi et al. Oct 2002 B1
6472518 Ribot et al. Oct 2002 B1
6475732 Shayesteh et al. Nov 2002 B1
6475789 Cech et al. Nov 2002 B1
6477426 Fenn et al. Nov 2002 B1
6482182 Carroll et al. Nov 2002 B1
6482599 Mikolajczyk et al. Nov 2002 B1
6485308 Goldstein Nov 2002 B1
6485436 Truckai et al. Nov 2002 B1
6485905 Hefti Nov 2002 B2
6488636 Bryan et al. Dec 2002 B2
6489097 Hirose et al. Dec 2002 B2
6489113 Traish Dec 2002 B1
6490467 Bucholz et al. Dec 2002 B1
6491699 Henderson et al. Dec 2002 B1
6491702 Heilbrun et al. Dec 2002 B2
6492115 Guida et al. Dec 2002 B1
6494844 Van Bladel et al. Dec 2002 B1
6494859 Love et al. Dec 2002 B2
6494879 Lennox et al. Dec 2002 B2
6495130 Henderson et al. Dec 2002 B1
6496717 Cox et al. Dec 2002 B2
6497706 Burbank et al. Dec 2002 B1
6500622 Bruchez, Jr. et al. Dec 2002 B2
6500938 Au-Young et al. Dec 2002 B1
6505125 Ho Jan 2003 B1
6506156 Jones et al. Jan 2003 B1
6506607 Shyjan Jan 2003 B1
6507748 Selland Jan 2003 B2
6508755 Ravins et al. Jan 2003 B1
6508789 Sinnott et al. Jan 2003 B1
6509458 Afar et al. Jan 2003 B1
6509514 Kneteman et al. Jan 2003 B1
6514248 Eggers et al. Feb 2003 B1
6514251 Ni et al. Feb 2003 B1
6514685 Moro Feb 2003 B1
6514695 Barsky et al. Feb 2003 B1
6517498 Burbank et al. Feb 2003 B1
6521211 Unger et al. Feb 2003 B1
6524800 Lockhart et al. Feb 2003 B2
6527731 Weiss et al. Mar 2003 B2
6530888 Smith et al. Mar 2003 B2
6535756 Simon et al. Mar 2003 B1
6537761 Shayesteh et al. Mar 2003 B1
6538119 Billing-Medel et al. Mar 2003 B2
6540694 Van Bladel et al. Apr 2003 B1
6540695 Burbank et al. Apr 2003 B1
6544236 Cragg et al. Apr 2003 B1
6544544 Hunter et al. Apr 2003 B2
6546787 Schiller et al. Apr 2003 B1
6548257 Lockhart et al. Apr 2003 B2
6551255 Van Bladel et al. Apr 2003 B2
6551784 Fodor et al. Apr 2003 B2
6552164 Colpitts et al. Apr 2003 B1
6552181 Dean et al. Apr 2003 B1
6554779 Viola et al. Apr 2003 B2
6558407 Ivanko et al. May 2003 B1
6558916 Veerapandian et al. May 2003 B2
6562562 Casu' et al. May 2003 B2
6564087 Pitris et al. May 2003 B1
6564806 Fogarty et al. May 2003 B1
6566078 Raitano et al. May 2003 B1
6566079 Hefti May 2003 B2
6567214 Lorincz May 2003 B2
6567689 Burbank et al. May 2003 B2
6568941 Goldstein May 2003 B1
6572551 Smith et al. Jun 2003 B1
6572578 Blanchard Jun 2003 B1
6577904 Zhang et al. Jun 2003 B1
6579891 Fernandez-Pol Jun 2003 B1
6580938 Acker Jun 2003 B1
6582368 Holdaway et al. Jun 2003 B2
6582426 Moorman et al. Jun 2003 B2
6585968 Little et al. Jul 2003 B2
6586713 Essenfeld et al. Jul 2003 B2
6587578 Godik et al. Jul 2003 B2
6589240 Hinchliffe Jul 2003 B2
6592508 Ravins et al. Jul 2003 B1
6592530 Farhadi Jul 2003 B1
6599247 Stetten Jul 2003 B1
6602659 Waldman et al. Aug 2003 B1
6604404 Paltieli et al. Aug 2003 B2
6605294 Sawhney Aug 2003 B2
6607561 Brannon Aug 2003 B2
6608191 Anderson et al. Aug 2003 B1
6608310 Soluri et al. Aug 2003 B2
6610016 Violante et al. Aug 2003 B1
6610499 Fulwyler et al. Aug 2003 B1
6610839 Morin et al. Aug 2003 B1
6612991 Sauer et al. Sep 2003 B2
6613740 Gozes et al. Sep 2003 B1
6614921 Chung et al. Sep 2003 B1
6617110 Chech et al. Sep 2003 B1
6617137 Dean et al. Sep 2003 B2
6623437 Hinchliffe et al. Sep 2003 B2
6626832 Paltieli et al. Sep 2003 B1
6626848 Neuenfeldt Sep 2003 B2
6626850 Chau et al. Sep 2003 B1
6626903 McGuckin, Jr. et al. Sep 2003 B2
6626930 Allen et al. Sep 2003 B1
6627414 Billing-Medel et al. Sep 2003 B2
6627461 Chapman et al. Sep 2003 B2
6629959 Kuracina et al. Oct 2003 B2
6631204 Smith Oct 2003 B1
6632183 Bowman et al. Oct 2003 B2
6638234 Burbank et al. Oct 2003 B2
6638719 Gunderson et al. Oct 2003 B1
6638727 Hung et al. Oct 2003 B1
6645731 Terstappen et al. Nov 2003 B2
6647285 Da Silva et al. Nov 2003 B2
6649420 Cantor Nov 2003 B1
6652520 Moorman et al. Nov 2003 B2
6652859 Afar et al. Nov 2003 B1
6653080 Bruchez et al. Nov 2003 B2
6653129 Bander et al. Nov 2003 B1
6654120 Ban Nov 2003 B2
6654629 Montegrande Nov 2003 B2
6656132 Ouchi Dec 2003 B1
6659105 Burbank et al. Dec 2003 B2
6660834 Billing-Medel et al. Dec 2003 B2
6662041 Burbank et al. Dec 2003 B2
6663560 MacAulay et al. Dec 2003 B2
6666811 Good Dec 2003 B1
6670122 Rosenow et al. Dec 2003 B2
6673023 Pflueger Jan 2004 B2
6673914 Hoon Jan 2004 B1
6675037 Tsekos Jan 2004 B1
6676610 Morton et al. Jan 2004 B2
6676658 Burbank et al. Jan 2004 B2
6676935 Henderson et al. Jan 2004 B2
6676984 Sharp et al. Jan 2004 B1
6677157 Cohen Jan 2004 B1
6678545 Bucholz Jan 2004 B2
6678552 Pearlman Jan 2004 B2
6679851 Burbank et al. Jan 2004 B2
6680178 Harris et al. Jan 2004 B2
6689062 Mesallum Feb 2004 B1
6689065 Aksnes et al. Feb 2004 B2
6689067 Sauer et al. Feb 2004 B2
6689071 Burbank et al. Feb 2004 B2
6689072 Kaplan et al. Feb 2004 B2
6689073 Quay Feb 2004 B2
6689744 Gao et al. Feb 2004 B2
6689787 McKearn et al. Feb 2004 B1
6690371 Okerlund et al. Feb 2004 B1
6690966 Rava et al. Feb 2004 B1
6690976 Fenn et al. Feb 2004 B2
6692467 McFarlane Feb 2004 B2
6692724 Yang et al. Feb 2004 B1
6692736 Yu et al. Feb 2004 B2
6695779 Sauer et al. Feb 2004 B2
6697665 Rava et al. Feb 2004 B1
6699205 Fulton, III et al. Mar 2004 B2
6702749 Paladini et al. Mar 2004 B2
6702761 Damadian et al. Mar 2004 B1
6702831 Lee et al. Mar 2004 B2
6703216 Parsons et al. Mar 2004 B2
6705994 Vortman et al. Mar 2004 B2
6709408 Fisher Mar 2004 B2
6709816 Huang et al. Mar 2004 B1
6712773 Viola Mar 2004 B1
6712785 Morton et al. Mar 2004 B2
6714808 Klimberg et al. Mar 2004 B2
6716179 Burbank et al. Apr 2004 B2
6722371 Fogarty et al. Apr 2004 B1
6723052 Mills Apr 2004 B2
6723106 Charles et al. Apr 2004 B1
6723498 Shyjan et al. Apr 2004 B1
6725080 Melkent et al. Apr 2004 B2
6725083 Burbank et al. Apr 2004 B1
6725095 Fenn et al. Apr 2004 B2
6726651 Robinson et al. Apr 2004 B1
6728334 Zhao Apr 2004 B1
6730042 Fulton et al. May 2004 B2
6730045 Finer May 2004 B2
6731966 Spigelman et al. May 2004 B1
6733969 Mack May 2004 B2
6738663 Schroeppel et al. May 2004 B2
6746844 Oliner et al. Jun 2004 B2
6749588 Howell Jun 2004 B1
6750015 Horwitz et al. Jun 2004 B2
6752154 Fogarty et al. Jun 2004 B2
6752767 Turovskiy et al. Jun 2004 B2
6752768 Burdorff et al. Jun 2004 B2
6752769 Alberico Jun 2004 B2
6753138 Schneider et al. Jun 2004 B1
6758848 Burbank et al. Jul 2004 B2
6764449 Lee et al. Jul 2004 B2
6764495 Lee et al. Jul 2004 B2
6766186 Hoyns et al. Jul 2004 B1
6767704 Waldman et al. Jul 2004 B2
6768925 Fenn et al. Jul 2004 B2
6770066 Weaver et al. Aug 2004 B1
6770070 Balbierz Aug 2004 B1
6770435 Billing-Medel et al. Aug 2004 B1
6770770 Baumann et al. Aug 2004 B1
6773903 Bova Aug 2004 B2
6776757 Larson et al. Aug 2004 B2
6780984 Wang et al. Aug 2004 B2
6785410 Vining et al. Aug 2004 B2
6786870 Miyaki et al. Sep 2004 B2
6788977 Fenn et al. Sep 2004 B2
6790185 Fisher et al. Sep 2004 B1
6797477 Guida et al. Sep 2004 B2
6805669 Swanbom Oct 2004 B2
6805869 Guo Oct 2004 B2
6806712 Akgun Oct 2004 B2
6807444 Tu et al. Oct 2004 B2
6808878 Gray et al. Oct 2004 B1
6818184 Fulwyler et al. Nov 2004 B2
6818750 Reed Nov 2004 B2
6819785 Vining et al. Nov 2004 B1
6821725 Carrasco et al. Nov 2004 B1
6824780 Devaux et al. Nov 2004 B1
6824974 Pisharody et al. Nov 2004 B2
6824995 Wu Nov 2004 B1
6827692 Castellacci Dec 2004 B2
6831059 Donovan Dec 2004 B2
6832111 Tu et al. Dec 2004 B2
6833373 McKearn et al. Dec 2004 B1
6833438 Afar et al. Dec 2004 B1
6835183 Lennox et al. Dec 2004 B2
6835572 Mountford et al. Dec 2004 B1
6838243 Lai et al. Jan 2005 B2
6840952 Saker et al. Jan 2005 B2
6841350 Ogden et al. Jan 2005 B2
6843980 Green Jan 2005 B2
6844153 Waldman et al. Jan 2005 B2
6846320 Ashby et al. Jan 2005 B2
6846650 Recipon et al. Jan 2005 B2
6846911 Kelly Jan 2005 B2
6847841 El Hatw Jan 2005 B1
6849080 Lee et al. Feb 2005 B2
6850588 Arenson et al. Feb 2005 B2
6852528 Yu et al. Feb 2005 B2
6855517 Salceda et al. Feb 2005 B2
6855554 Fritsche et al. Feb 2005 B2
6858412 Willis et al. Feb 2005 B2
6858598 McKearn et al. Feb 2005 B1
6858711 McGall et al. Feb 2005 B2
6859049 Khatchatrian et al. Feb 2005 B2
6860855 Shelby et al. Mar 2005 B2
6860860 Viola Mar 2005 B2
6863676 Lee et al. Mar 2005 B2
6864224 Sedivy et al. Mar 2005 B1
6866630 Larson et al. Mar 2005 B2
6866993 Williamson Mar 2005 B1
6866994 Morton Mar 2005 B2
6867016 Billing-Medel et al. Mar 2005 B1
6867753 Chinthammit et al. Mar 2005 B2
6871086 Nevo et al. Mar 2005 B2
6872184 Brannon Mar 2005 B2
6872185 Fisher Mar 2005 B2
6872389 Faris Mar 2005 B1
6875182 Wardle et al. Apr 2005 B2
6875184 Morton et al. Apr 2005 B2
6883194 Corbeil et al. Apr 2005 B2
6883958 Mayer Apr 2005 B2
6884578 Warrington et al. Apr 2005 B2
6884605 Hermonat et al. Apr 2005 B2
6887210 Quay May 2005 B2
6888919 Graf May 2005 B2
6890308 Islam May 2005 B2
6890309 Fisher May 2005 B2
6890311 Love et al. May 2005 B2
6890749 Billing-Medel et al. May 2005 B2
6893818 Afar et al. May 2005 B1
6893868 Packard et al. May 2005 B2
6894026 Quay May 2005 B1
6899696 Morton et al. May 2005 B2
6900015 Avihingsanon et al. May 2005 B2
6900049 Yu et al. May 2005 B2
6901278 Notelovitz May 2005 B1
6904305 Tsekos Jun 2005 B2
6904309 Derendorf et al. Jun 2005 B2
6905475 Hauschild et al. Jun 2005 B2
6908440 Fisher Jun 2005 B2
6913882 Glynne et al. Jul 2005 B2
6914130 Gao et al. Jul 2005 B2
6916800 McKearn et al. Jul 2005 B2
6916918 Yu et al. Jul 2005 B2
6918881 Miller et al. Jul 2005 B2
6919176 Yang et al. Jul 2005 B2
6920347 Simon et al. Jul 2005 B2
RE38776 Bauer Aug 2005 E
6923809 Eggers et al. Aug 2005 B2
6924094 Gingeras et al. Aug 2005 B1
6925389 Hitt et al. Aug 2005 B2
6926893 Hansen Aug 2005 B1
6927032 Lockhart et al. Aug 2005 B2
6933105 Jin Aug 2005 B2
6936014 Vetter et al. Aug 2005 B2
6936416 Zhu et al. Aug 2005 B2
6936687 Komoriya et al. Aug 2005 B1
6942985 Waldman Sep 2005 B2
6943236 Xu et al. Sep 2005 B2
6944505 Zhang et al. Sep 2005 B2
6945942 Van Bladel et al. Sep 2005 B2
6947584 Avila et al. Sep 2005 B1
6949357 Billing-Medel et al. Sep 2005 B2
6953691 Reed et al. Oct 2005 B2
6954667 Treado et al. Oct 2005 B2
6955653 Eggers Oct 2005 B2
6965793 Treado et al. Nov 2005 B2
6994712 Fisher et al. Feb 2006 B1
D518175 Hardin, Jr. et al. Mar 2006 S
7014610 Koulik Mar 2006 B2
7025765 Balbierz et al. Apr 2006 B2
7067111 Yang et al. Jun 2006 B1
7067274 Fairbrother et al. Jun 2006 B2
7070816 Newmark et al. Jul 2006 B2
7072704 Bucholz Jul 2006 B2
7074600 Dean et al. Jul 2006 B2
7077842 Cosman Jul 2006 B1
7079132 Sauer et al. Jul 2006 B2
7081340 Baker et al. Jul 2006 B2
7083547 LaStayo et al. Aug 2006 B2
7083985 Hefti et al. Aug 2006 B2
7087393 Billing-Medel et al. Aug 2006 B2
7089121 Wang Aug 2006 B1
7090845 Fong et al. Aug 2006 B2
7090862 Barrett-Reis et al. Aug 2006 B2
7091047 Serrero Aug 2006 B2
7094233 Desinger Aug 2006 B2
7101663 Godfrey et al. Sep 2006 B2
7101862 Cochrum et al. Sep 2006 B2
7108969 Warrington et al. Sep 2006 B1
7115368 Powers et al. Oct 2006 B2
7118876 Tyner et al. Oct 2006 B2
7118910 Unger et al. Oct 2006 B2
7122011 Clifford et al. Oct 2006 B2
7122653 Cohen et al. Oct 2006 B2
7125836 Woodward Oct 2006 B2
7125969 Benz et al. Oct 2006 B1
7128877 Quay et al. Oct 2006 B2
7128893 Leamon et al. Oct 2006 B2
7129048 Bruchez et al. Oct 2006 B2
7131951 Angel Nov 2006 B2
7135333 Waldman et al. Nov 2006 B1
7139601 Bucholz et al. Nov 2006 B2
7141019 Pearlman Nov 2006 B2
7144950 Bazan et al. Dec 2006 B2
7153700 Pardee et al. Dec 2006 B1
7156814 Williamson, IV et al. Jan 2007 B1
7156815 Leigh et al. Jan 2007 B2
7160292 Moorman et al. Jan 2007 B2
7161057 Kneteman et al. Jan 2007 B2
7169114 Krause Jan 2007 B2
7172558 Olson, Jr. Feb 2007 B2
7172739 Maughan Feb 2007 B2
7175839 Hiserodt Feb 2007 B1
7183251 Russo et al. Feb 2007 B1
D538933 Andrade Mar 2007 S
7186522 Lapen et al. Mar 2007 B2
7189206 Quick et al. Mar 2007 B2
7189207 Viola Mar 2007 B2
7190378 Sauer et al. Mar 2007 B2
7192570 Maecke et al. Mar 2007 B2
7195774 Carvalho et al. Mar 2007 B2
7195868 Iartchouk et al. Mar 2007 B2
7195911 Cech et al. Mar 2007 B2
7196182 Reed et al. Mar 2007 B2
7198896 Rush et al. Apr 2007 B2
7199234 Morin et al. Apr 2007 B2
7204988 Cheung Apr 2007 B2
7207985 Duong et al. Apr 2007 B2
7208146 Denney, Jr. Apr 2007 B2
7208267 Salceda et al. Apr 2007 B2
7211398 Astle et al. May 2007 B2
7214489 Bazan et al. May 2007 B2
7217276 Henderson et al. May 2007 B2
7217394 Studer May 2007 B2
7218959 Alfano et al. May 2007 B2
7220258 Myhr May 2007 B2
7220891 Barsky et al. May 2007 B2
7223238 Swanbom May 2007 B2
7223380 Yang et al. May 2007 B2
7223540 Pourmand et al. May 2007 B2
7223542 Raitano et al. May 2007 B2
7226731 Chuaqui et al. Jun 2007 B1
7227009 Craik et al. Jun 2007 B2
7229413 Violante et al. Jun 2007 B2
7229417 Foerster et al. Jun 2007 B2
7229439 Burbank et al. Jun 2007 B2
7229604 Yang et al. Jun 2007 B2
7229774 Chinnaiyan et al. Jun 2007 B2
7231015 Kumakhov Jun 2007 B2
7235047 MacAulay et al. Jun 2007 B2
7236816 Kumar et al. Jun 2007 B2
7241736 Hunter et al. Jul 2007 B2
7244619 Contreras et al. Jul 2007 B2
7245748 Degani et al. Jul 2007 B2
7245958 Navab et al. Jul 2007 B1
7247426 Yakhini et al. Jul 2007 B2
7250180 Arellano Jul 2007 B2
7250264 Fong et al. Jul 2007 B2
7250551 Tsai et al. Jul 2007 B2
7251352 Sauer et al. Jul 2007 B2
7251568 Pittman et al. Jul 2007 B2
7252935 Sidransky Aug 2007 B2
7252946 Szasz Aug 2007 B2
7252948 Gingeras et al. Aug 2007 B2
7258973 Astle et al. Aug 2007 B2
7261712 Burbank et al. Aug 2007 B2
7261875 Li et al. Aug 2007 B2
7262288 Cech et al. Aug 2007 B1
7264947 Gozes et al. Sep 2007 B2
7270956 Bazan et al. Sep 2007 B2
7271187 Neuberger et al. Sep 2007 B2
7274810 Reeves et al. Sep 2007 B2
7314481 Karpiel Jan 2008 B2
7356828 Townsend et al. Apr 2008 B2
7608056 Kennedy, II Oct 2009 B2
8109953 King, III et al. Feb 2012 B1
D657461 Schembre et al. Apr 2012 S
8162958 Takahashi et al. Apr 2012 B2
8187203 McClellan May 2012 B2
8262680 Swain et al. Sep 2012 B2
8328772 Kinast et al. Dec 2012 B2
8357193 Phan et al. Jan 2013 B2
8361041 Fang et al. Jan 2013 B2
8454632 Binmoeller et al. Jun 2013 B2
8486010 Nomura Jul 2013 B2
D690009 Schembre et al. Sep 2013 S
8968210 Mugan et al. Mar 2015 B2
9186128 Mugan et al. Nov 2015 B2
20010007925 Ritchart et al. Jul 2001 A1
20010023322 Espositio et al. Sep 2001 A1
20010047183 Privitera et al. Nov 2001 A1
20010056218 Hogendijk et al. Dec 2001 A1
20020035324 Sirimanne et al. Mar 2002 A1
20020082519 Miller et al. Jun 2002 A1
20020156395 Stephens et al. Oct 2002 A1
20020169418 Menz et al. Nov 2002 A1
20030078502 Miyaki et al. Apr 2003 A1
20030093007 Wood May 2003 A1
20030105488 Chu Jun 2003 A1
20030139752 Pasricha et al. Jul 2003 A1
20030163142 Paltieli et al. Aug 2003 A1
20030181823 Gatto Sep 2003 A1
20030195436 Van Bladel et al. Oct 2003 A1
20030204137 Chesbrough et al. Oct 2003 A1
20030208134 Secrest et al. Nov 2003 A1
20030208219 Aznolan et al. Nov 2003 A1
20030212394 Pearson et al. Nov 2003 A1
20030233101 Lubock et al. Dec 2003 A1
20040073219 Skiba et al. Apr 2004 A1
20040077948 Violante et al. Apr 2004 A1
20040153005 Krueger Aug 2004 A1
20040167429 Roshdieh et al. Aug 2004 A1
20040236212 Jones et al. Nov 2004 A1
20040249395 Mikkaichi et al. Dec 2004 A1
20040260199 Hardia, Jr. et al. Dec 2004 A1
20040260274 Hardin et al. Dec 2004 A1
20050021003 Caso et al. Jan 2005 A1
20050022493 Olinger et al. Feb 2005 A1
20050061697 Moberg Mar 2005 A1
20050090801 Racz et al. Apr 2005 A1
20050113715 Schwindt et al. May 2005 A1
20050143753 Whitmore et al. Jun 2005 A1
20050159676 Taylor et al. Jul 2005 A1
20050192535 Takagi et al. Sep 2005 A1
20050197623 Leeflang et al. Sep 2005 A1
20050228311 Beckman et al. Oct 2005 A1
20050228312 Surti Oct 2005 A1
20050228413 Binmoeller et al. Oct 2005 A1
20050251111 Saito et al. Nov 2005 A1
20050256426 Brugge Nov 2005 A1
20050272975 Mcweeney et al. Dec 2005 A1
20060052750 Lenker et al. Mar 2006 A1
20060100654 Fukuda et al. May 2006 A1
20060116605 Nakao Jun 2006 A1
20060142789 Lehman et al. Jun 2006 A1
20060155210 Beckman et al. Jul 2006 A1
20060155246 Higuchi Jul 2006 A1
20060167416 Mathis et al. Jul 2006 A1
20060189891 Waxman et al. Aug 2006 A1
20060235298 Kotmel et al. Oct 2006 A1
20060247530 Hardin et al. Nov 2006 A1
20060258955 Hoffman et al. Nov 2006 A1
20060264919 Schaaf Nov 2006 A1
20070023304 Joyce et al. Feb 2007 A1
20070032741 Hibner et al. Feb 2007 A1
20070038089 Hatano et al. Feb 2007 A1
20070055173 Delonzor et al. Mar 2007 A1
20070056360 Grant et al. Mar 2007 A1
20070060837 Cho et al. Mar 2007 A1
20070118049 Viola May 2007 A1
20070123799 Meireles May 2007 A1
20070123800 Nishtala et al. May 2007 A1
20070149893 Heske et al. Jun 2007 A1
20070177009 Bayer et al. Aug 2007 A1
20070179403 Heske et al. Aug 2007 A1
20070185411 Hibner Aug 2007 A1
20070213633 McClellan Sep 2007 A1
20070213634 Teague Sep 2007 A1
20070260258 Sommerich Nov 2007 A1
20070299306 Parasher et al. Dec 2007 A1
20080058637 Fischell et al. Mar 2008 A1
20080097344 McKinnon et al. Apr 2008 A1
20080097572 Sheldon et al. Apr 2008 A1
20080146962 Ritchie et al. Jun 2008 A1
20080147010 Nakajima et al. Jun 2008 A1
20080200912 Long Aug 2008 A1
20080294111 Tal et al. Nov 2008 A1
20080300462 Intoccia et al. Dec 2008 A1
20080319341 Taylor Dec 2008 A1
20090054773 Shizuka Feb 2009 A1
20090069679 Hibi Mar 2009 A1
20090099414 Goto et al. Apr 2009 A1
20090177114 Chin et al. Jul 2009 A1
20090182200 Golden et al. Jul 2009 A1
20090264794 Kodama Oct 2009 A1
20090312645 Weitzner et al. Dec 2009 A1
20100081965 Mugan et al. Apr 2010 A1
20100121218 Mugan et al. May 2010 A1
20100274085 Mugan et al. Oct 2010 A1
20110054381 Van Dam Mar 2011 A1
20110071350 Van Dam et al. Mar 2011 A1
20110137394 Lunsford et al. Jun 2011 A1
20110152886 Sato et al. Jun 2011 A1
20120029278 Sato et al. Feb 2012 A1
20120116248 McWeeney et al. May 2012 A1
20120136426 Phan et al. May 2012 A1
20120157880 Haselby et al. Jun 2012 A1
20120172896 Takahashi et al. Jul 2012 A1
20120245486 Melchiorr et al. Sep 2012 A1
20120253228 Schembre et al. Oct 2012 A1
20120296257 Van Dam et al. Nov 2012 A1
20130041286 Theobald et al. Feb 2013 A1
20130110141 Chmura May 2013 A1
20130131547 Hardert et al. May 2013 A1
20130131548 McGhie et al. May 2013 A1
20130253546 Sander et al. Sep 2013 A1
20130253550 Beisel et al. Sep 2013 A1
20130310833 Brown et al. Nov 2013 A1
20130325038 Sato Dec 2013 A1
20140005478 Kennedy, II et al. Jan 2014 A1
20140088684 Paskar Mar 2014 A1
Foreign Referenced Citations (55)
Number Date Country
0704189 Apr 1996 EP
0739640 Apr 1996 EP
0738501 Oct 1996 EP
1923003 Sep 2006 EP
1870051 Dec 2007 EP
2030574 Mar 2009 EP
2367481 Sep 2011 EP
09818508 Sep 2011 EP
06189965 Jul 1994 JP
7116169 May 1995 JP
8-38482 Mar 1996 JP
9-135836 May 1997 JP
2009122067 May 1997 JP
200213604 May 2002 JP
2004181095 Feb 2004 JP
2005058431 Mar 2005 JP
2007-513692 May 2007 JP
20073132538 May 2007 JP
3132538 Jun 2007 JP
86005324 Sep 1986 WO
92000039 Jan 1992 WO
9204062 Mar 1992 WO
00009178 Feb 2000 WO
0033909 Jun 2000 WO
00046626 Aug 2000 WO
2004066828 Aug 2004 WO
2004066829 Aug 2004 WO
2004073509 Sep 2004 WO
2004107988 Dec 2004 WO
2005020905 Mar 2005 WO
2005081032 Sep 2005 WO
2005081033 Sep 2005 WO
2005096953 Oct 2005 WO
2005096963 Oct 2005 WO
2005112797 Dec 2005 WO
2005120345 Dec 2005 WO
2006014011 Feb 2006 WO
2006028281 Mar 2006 WO
2006057443 Jun 2006 WO
2006064972 Jun 2006 WO
2007021904 Feb 2007 WO
2007021904 Feb 2007 WO
2007081039 Jul 2007 WO
2007081041 Jul 2007 WO
2007081050 Jul 2007 WO
2007081056 Jul 2007 WO
2007138674 Dec 2007 WO
2008020157 Feb 2008 WO
2008020439 Feb 2008 WO
2008024684 Feb 2008 WO
2008044013 Apr 2008 WO
2010039955 Apr 2010 WO
2010062895 Jun 2010 WO
2012112202 Aug 2012 WO
2013074653 May 2013 WO
Non-Patent Literature Citations (28)
Entry
Creganna Needle Brochure, Published Jan. 16, 2008.
Iglesias-Garcia, 2011, Feasibility and Yield of a New EUS Histology Needle: Results from a Multicenter, Pooled, Cohort Study, Gastrointestinal Endoscopy 73(6); 909-915.
Washita, 2013, High Single-Pass Diagnostic Yield of a new 25-Guage Core Biopsy Needle for EUS-Guided FNa biopsy in Solic Pancreatic Lesions, Gastrointestinal Endoscopy 77(6); 909-915.
Kaheleh, 2013, Endoscopic Ultrasonography guided biliary drainage: Summary of consortium meeting, May 7, 2011, Chicago, World Journal of Gastroenterology, 19(9); 1372-1379.
Khashab, 2013, EUS-Guided biliary drainage by using a standardized approach for malignant biliary obstructions: Rendezvous Versus Direct Transluminal techniques, Gastrointestinal Endoscopy; 1-8.
Park, 2011, EUS-guided Biliary Drainage with Transluminal stenting after Failed ERCP: predictors of Adverse Events and long-term Results, Gastrointestinal Endoscopy 74(6); 1276-1284.
Park, 2013, Prospective Evaluation of a Treatment Algorithm with Enhanced Guidewire Manipulation Protocol for EUS-Guided Biliary Drainage after failed ERCP, Gastrointestinal Endoscopy 78(1); 92-101.
Pelaez-Luna, 2008, Interventional EUS Guided Cholangiography. First Description in Mexico of a Novel, Secure and Feasible Technique. A Case Report, Caso Clinico.
Patent Examination Report No. 1 for Patent App. No. 2012339659, dated Sep. 22, 2016, from Australian Government IP Australia.
Notice of Allowance for JP 2014-542405 dated Oct. 6, 2016 from the Japanese Patent Office.
Notice of Reasons for Rejection, dated Jun. 17, 2016, for Japanese Patent App. No. 2014-542405, from Japanese Patent Office.
Canadian Office Action for App. No. 2,744,612 from the Canadian Intellectual Property Office dated Oct. 27, 2016.
Examiner's Report for Canadian App. No. 2,995,281 dated Oct. 19, 2018.
Notice of Reasons for Rejection for JP App No. 2014-236354 dated Dec. 9, 2015.
Examination Report from Canadian Intellectual Property Office for App. No. 2,899,073 dated May 6, 2016.
International Search Report and Written Opinion issued in PCT/US2011/060981, dated Jun. 11, 2012.
International Search Report and Written Opinion issued in PCT/US2009/065705 dated Jul. 7, 2010.
International Search Report for PCT/US2009/059226 dated Apr. 28, 2010.
International Search Report for PCT/US2008/088431 dated Jul. 27, 2009.
International Search Report and Written Opinion issued in PCT/US2012/065049 dated May 2, 2013.
International Search Report and Written Opinion issued in PCT/JP2007053498 dated Mar. 20, 2007.
International Search Report for PCT/US2004/040221 dated Jun. 13, 2005.
International Search Report for PCT/US2012/065049 dated Feb. 22, 2013.
Examination Report for App. No. 09829751.8 dated Feb. 10, 2015.
Office Action for Canadian App. No. 2,739,391 dated Dec. 7, 2015.
Translation of Office Action for Japanese App. No. 2014-236354 dated Dec. 9, 2015.
Examination Report for App. No. 09829751.8 dated Sep. 17, 2015.
Examination Report dated Nov. 25, 2020 Application No. 09818508.5—Covidien LP.
Related Publications (1)
Number Date Country
20180235585 A1 Aug 2018 US
Continuations (2)
Number Date Country
Parent 14630742 Feb 2015 US
Child 15886293 US
Parent 12607636 Oct 2009 US
Child 14630742 US
Continuation in Parts (1)
Number Date Country
Parent 12243367 Oct 2008 US
Child 12607636 US